CohBar Inc. (NASDAQ:CWBR) is up 6% in a week. The company recently appointed Carol Nast to its Board as an independent director, effective as of August 11, 2021. Nast has tremendous experience in executive positions in early-stage and large multinational corporations in the medical sector.
CohBar Chairman David Greenwood said they are delighted to welcome Nast to the company during this development moment. Greenwood said that Nast brings considerable operational and commercial expertise that will help the company progress in creating its proprietary mitochondria-based therapeutics platform. Nast said that the company is carrying work in addressing unmet medical needs through its novel therapeutics, and this is an interesting period to join.
The company has announced that its CEO Joseph Sarret will present CohBar’s overview at various investor conferences this month. The conferences include the H.C Wainwright Annual Global Investment Conference on September 13-15, 2021, and the Cantor Fitzgerald Virtual Global Healthcare Conference on September 30, 2021. So, CWBR is worth watching in the coming weeks.
On Thursday, CWBR stock jumped 2.42% at $1.27 with more than 639K shares, compared to its average volume of 3.50 million shares. The stock has moved within a range of $1.2486 – 1.3200 after opening the trade at $1.26.